US/UK/Canada

Share

Contacts

  • AstraZeneca
    Karlebyhus, Astraallén 151 85 SÖDERTÄLJE
    08-553 260 00
    08-553 290 00
    http://www.astrazeneca.se
    • Pick a time period -
    Tags ( Active)

    Återköp av aktier - information om utskick

    Vi ser över hur vi kan effektivisera och förenkla vår kommunikation. Denna information finns framöver på bifogad länk. Informationen finns även tillgänglig på astrazeneca.se/aktieägare/aktieinformation. Detta utskick upphör därför per 1/6 2012. Vi frågor, kontakta: Ann-Leena Mikiver, presschef, 08-553 26020. http://www.londonstockexchange.com/exchange/news/market-news/market-news-home.htmlREPURCHASE OF SHARES IN ASTRAZENECA PLC AstraZeneca PLC announced that on 31 May 2012, it purchased for cancellation 132,000 ordinary shares of AstraZeneca PLC at a price of 2605 pence per share.

    Återköp av aktier i AstraZeneca PLC 17-21 maj 2012

    REPURCHASE OF SHARES IN ASTRAZENECA PLC AstraZeneca PLC announced that on 18 May 2012, it purchased for cancellation 600,000 ordinary shares of AstraZeneca PLC at a price of 2624 pence per share. Upon the cancellation of these shares, the number of shares in issue will be 1,265,183,783. A C N Kemp Company Secretary 21 May 2012 REPURCHASE OF SHARES IN ASTRAZENECA PLC AstraZeneca PLC announced that on 17 May 2012, it purchased for cancellation 360,000 ordinary shares of AstraZeneca PLC at a price of 2638 pence per share. Upon the cancellation of these shares, the number of

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 315,751 ordinary shares of AstraZeneca PLC at a price of 2691 pence per share on 11 May 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,267,634,390. A C N Kemp Company Secretary 14 May 2012

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 316,391 ordinary shares of AstraZeneca PLC at a price of 2685 pence per share on 9 May 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,268,256,452. A C N Kemp Company Secretary 10 May 2012

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 313,798 ordinary shares of AstraZeneca PLC at a price of 2709 pence per share on 8 May 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,268,566,549. A C N Kemp Company Secretary 9 May 2012

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 311,479 ordinary shares of AstraZeneca PLC at a price of 2730 pence per share on 4 May 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,269,166,468. A C N Kemp Company Secretary 8 May 2012

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 311,816 ordinary shares of AstraZeneca PLC at a price of 2727 pence per share on 3 May 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,269,163,885. A C N Kemp Company Secretary 4 May 2012

    Återköp i AstraZeneca 25 april 2012 till 3 maj 2012

    REPURCHASE OF SHARES IN ASTRAZENECA PLC Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 313,590 ordinary shares of AstraZeneca PLC at a price of 2710 pence per share on 2 May 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,269,470,811. A C N Kemp Company Secretary 3 May 2012 REPURCHASE OF SHARES IN ASTRAZENECA PLC Further to the announcement of its

    Återköp i AstraZeneca PLC 16 april till 24 april 2012

    REPURCHASE OF SHARES IN ASTRAZENECA PLC Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 301,492 ordinary shares of AstraZeneca PLC at a price of 2823 pence per share on 23 April 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,271,212,101. A C N Kemp Company Secretary 24 April 2012 REPURCHASE OF SHARES IN ASTRAZENECA PLC Further to the announcement of its

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 304,443 ordinary shares of AstraZeneca PLC at a price of 2795 pence per share on 12 April 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,272,470,727. A C N Kemp Company Secretary 13 April 2012

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 305,177 ordinary shares of AstraZeneca PLC at a price of 2788 pence per share on 10 April 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,272,934,176. A C N Kemp Company Secretary 11 April 2012

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 306,488 ordinary shares of AstraZeneca PLC at a price of 2776 pence per share on 5 April 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,273,171,200. A C N Kemp Company Secretary 10 April 2012

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 303,195 ordinary shares of AstraZeneca PLC at a price of 2807 pence per share on 4 April 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,273,444,803. A C N Kemp Company Secretary 5 April 2012 REPURCHASE OF SHARES IN ASTRAZENECA PLC Further to the announcement of its irrevocable, non-discretionary share

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 303,743 ordinary shares of AstraZeneca PLC at a price of 2801 pence per share on 2 April 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,273,627,210. A C N Kemp Company Secretary 3 April 2012

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 305,437 ordinary shares of AstraZeneca PLC at a price of 2785 pence per share on 30 March 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,273,493,566. A C N Kemp Company Secretary 2 April 2012

    Återköp av aktier i AstraZeneca PLC 22 mars till 30 mars 2011

    REPURCHASE OF SHARES IN ASTRAZENECA PLC Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 305,304 ordinary shares of AstraZeneca PLC at a price of 2786 pence per share on 29 March 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,273,276,079. A C N Kemp Company Secretary 30 March 2012 REPURCHASE OF SHARES IN ASTRAZENECA PLC Further to the announcement of its

    REPURCHASE OF SHARES IN ASTRAZENECA PLC

    Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 298,733 ordinary shares of AstraZeneca PLC at a price of 2849 pence per share on 20 March 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,273,028,199. A C N Kemp Company Secretary 21 March 2012   Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe